Enzymit - About the company
Enzymit is a series A company based in Ness Ziona (Israel), founded in 2020 by Gideon Lapidoth and Dror Baran. It operates as a Developer of novel enzymes and cell-free bioproduction platforms for diverse markets. Enzymit has raised $15M in funding from Grove Ventures. The company has 98 active competitors, including 24 funded and 1 that has exited. Its top competitors include companies like Citrine Informatics, Polymerize IO and Molecule.one.
Company Details
Enzymit is creating a new transformation layer for manufacturing by combining computational enzyme design, deep learning, and a proprietary high-throughput discovery platform. We develop novel enzymatic pathways and run them in controllable cell-free production systems. This approach merges the selectivity of biology with the precision of chemistry, enabling cleaner and more efficient production. Our platform has been validated with pharmaceutical-grade hyaluronic acid (HA), produced at kilogram scale with superior consistency and purity compared to fermentation. We are now advancing toward commercial HA supply while expanding the platform to products like heparin and human milk oligosaccharides (HMOs).
- Website
- www.enzymit.com
- Phone Number
- +972 **********
Key Metrics
Founded Year
2020
Location
Ness Ziona, Israel
Stage
Series A
Total Funding
$15M in 3 rounds
Latest Funding Round
Investors
Ranked
3rd among 98 active competitors
Employee Count
28 as on Aug 31, 2026
Similar Companies
Sign up to download Enzymit's company profile
Enzymit's funding and investors
Enzymit has raised a total funding of $15M over 3 rounds. Its first funding round was on Mar 25, 2020. Its latest funding round was a Series A round on Sep 25, 2024 for $*****. 4 investors participated in its latest round. Enzymit has 7 institutional investors.
Here is the list of recent funding rounds of Enzymit:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 25, 2024 | 1698813 | Series A | 7791700 | 9069058 | 7760788 | 5133969 |
Apr 07, 2022 | 6302386 | Seed | 6178855 | 8898802 | 3957343 | 4707624 |
Mar 25, 2020 | 2506992 | Grant (prize money) | 9696578 | 5512977 | 2109266 |
View details of Enzymit's funding rounds and investors
Enzymit's founders and board of directors
Founder? Claim ProfileThe founders of Enzymit are Gideon Lapidoth and Dror Baran.
Here are the details of Enzymit's key team members:
- Gideon Lapidoth: Co-Founder & CEO of Enzymit and founder of 1 other company. Contact Info: 1 email address
- Dror Baran: Co-Founder & COO of Enzymit and founder of 1 other company.
View details of Enzymit's Founder profiles and Board Members
Enzymit's employee count trend
Enzymit has 28 employees as of Aug 26. Here is Enzymit's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Enzymit's Competitors and alternates
Top competitors of Enzymit include Citrine Informatics, Polymerize IO and Molecule.one. Here is the list of Top 10 competitors of Enzymit, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Citrine Informatics 2013, Redwood City (United States), Series C | Provider of AI-based solutions for materials informatics | $81.3M | 70/100 | |
2nd | Polymerize IO 2020, Singapore (Singapore), Series A | AI platform for material property prediction and design | $4.65M | 60/100 | |
3rd | Developer of novel enzymes and cell-free bioproduction platforms for diverse markets | $15M | 58/100 | ||
4th | Molecule.one 2016, Warsaw (Poland), Seed | Provider of AI-based software research for molecule drug designing and synthesis | $4.63M | 48/100 | |
5th | MaterialsZone 2017, Tel Aviv (Israel), Seed | Platform offering visual analytics solutions | $7M | 44/100 | |
6th | cheMastery 2018, London (United Kingdom), Seed | Developer of automation systems for chemical laboratories | $250K | 42/100 | |
7th | Provider of AI-driven solutions to revolutionize materials development cycles for various industries | $3.1M | 41/100 | ||
8th | Chemical.AI 2018, Markham (Canada), Series B | AI-driven tools for chemical synthesis and retrosynthesis | $18.6M | 41/100 | |
9th | Kebotix 2017, Cambridge (United States), Series B | AI solutions for materials discovery | $23.7M | 40/100 | |
10th | Aionics 2018, Evanston (United States), Series A | AI and cloud-based data, and models for battery manufacturing | $7.81M | - | 40/100 |
Looking for more details on Enzymit's competitors? Click here to see the top ones
Enzymit's Investments and acquisitions
Enzymit has made no investments or acquisitions yet.
Reports related to Enzymit
Here is the latest report on Enzymit's sector:
News related to Enzymit
Media has covered Enzymit for 1 event in last 1 year, It was about company updates.
•
Enzymit Achieves World's First Scaled Cell-Free Production of Hyaluronic AcidPR Newswire•Nov 10, 2025•Cosun, Enzymit
•
Enzymit raises $10 million Series A for cell-free bio-production technologyCTech•Sep 25, 2024•Enzymit, Grove Ventures, Khosla Ventures, First Star Ventures and 1 other
•
Enzymit Partners with Aleph Farms to Market Cultivated MeatFoodengineeringmag•May 24, 2023•Enzymit, Aleph Farms
•
Enzymit and Aleph Farms ally to develop cost-effective insulin substituents for cell-based meatFoodIngredientsFirst•May 17, 2023•Aleph Farms, Enzymit
•
Enzymit Raises $5M For Bio-Manufacturing Platform It Claims Can Replace FermentationThe Spoon•Apr 07, 2022•Enzymit
Are you a Founder ?
FAQs about Enzymit
Explore our recently published companies
- Seededge Solutions - Pune based, Unfunded company
- Secuarden AI - Melbourne based, 2026 founded, Unfunded company
- Secretair AI - France based, 2025 founded, Unfunded company
- Second Loop AI - Unfunded company
- Seawin AI - Unfunded company
- Seamless IT AI - United States based, Unfunded company